HOME >> BIOLOGY >> NEWS
Multicenter study nets new lung tumor-suppressor gene

BOSTON--Collaborating scientists in Boston and North Carolina have found that a particular gene can block key steps of the lung cancer process in mice. The researchers report in the journal Nature that LKB1 is not only a "tumor-suppressor" gene for non-small cell lung cancer in mice, it also may be more powerful than other, better-known suppressors. The study will be published on the journal's Web site on Aug. 5 and later in a print version.

If further research shows LKB1 has a similar effect in human lung cells, it could influence the way non-small cell lung cancer is diagnosed and treated, says the study's senior author, Kwok-Kin Wong, MD, PhD, of Dana-Farber, one of three institutions, along with Massachusetts General Hospital and the University of North Carolina School of Medicine, leading the work. If tumors with LKB1 mutations are found to be especially fast-growing, for example, patients with such tumors might be candidates for more aggressive therapy.

People born with defective versions of LKB1 often develop Peutz-Jeghers syndrome, which is marked by intestinal growths and an increased risk for certain cancers. Non-inherited mutations of the gene have been found in some lung cancers. This suggested that LKB1 normally thwarts tumors from forming. Mutated versions may be unable to act as a brake on cancer.

To find out, the investigators ran a series of experiments in mice with a defective form of a gene called Kras, which drives the formation and growth of lung cancer. They tracked the development of lung cancer in animals with mutated LKB1 and compared it to the experience of animals with abnormalities in either of two well-known tumor-suppressor genes.

They found that while Kras "cooperated" with the mutated tumor-suppressor genes to produce lung cancer, it cooperated even more strongly with mutated LKB1. The LKB1-deficient tumors grew more rapidly and spread more frequently than the others, and comprised all three
'"/>

Contact: Bill Schaller
william_schaller@dfci.harvard.edu
617-632-5357
Dana-Farber Cancer Institute
5-Aug-2007


Page: 1 2

Related biology news :

1. New study warns limited carbon market puts 20 percent of tropical forest at risk
2. Clones on task serve greater good, evolutionary study shows
3. Pollution causes 40 percent of deaths worldwide, study finds
4. A study by the MUHC and McGill University opens a new door to understanding cancer
5. New study suggests Concord grape juice may provide protection against breast cancer
6. Preclinical study links gene to brain aneurysm formation
7. In limiting life span, study finds booming bacteria innocent
8. MIT study: Maturity brings richer memories
9. Chickadee, nutchatch presence in conifers increases tree growth, says CU-Boulder study
10. Phase II study of therapeutic vaccine shows efficacy in patients with metastatic colorectal cancer
11. New study demonstrates important role of glia in circadian timing

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/9/2020)... (PRWEB) , ... March 09, ... ... enterprises witnessed a steep growth rate of 64% last year, as enterprises ... new research from Everest Group. Unfortunately, only 13% of all transformation efforts ...
(Date:3/5/2020)... DIEGO (PRWEB) , ... March ... ... today announces the formation of its Scientific Advisory Board (SAB) comprised of ... academic institutions, immune-oncology centers, cell therapy centers, and private industry. Cytonus is ...
(Date:3/5/2020)... (PRWEB) , ... March 05, 2020 , ... ... preparation and epigenetics research, and MGI Tech (MGI), a subsidiary of global genomics ... preparation product line in the United States, Europe and Asia Pacific. , ...
Breaking Biology News(10 mins):
(Date:3/19/2020)... ... March 17, 2020 , ... ... pioneering gene circuit company Senti Biosciences, Inc. (Senti) to accelerate the clinical ... tumor indications. The collaboration will leverage RoosterBio’s human mesenchymal stem/stromal cell (hMSC) ...
(Date:3/10/2020)... ... March 10, 2020 , ... Ortho Clinical Diagnostics, a ... laboratory solutions, announced its ORTHOTM Sera, ID-MTS, a suite of extended antigen in a ... cleared to run on ORTHO VISION® and ORTHO VISION® Max in the United States ...
(Date:3/4/2020)... ... ... This month, Cognosante will make its annual appearance at the HIMSS Global Health ... offerings that align with the HIMSS annual theme, “Be the Change.” , Cognosante’s ... From Interoperability and HIE to Cloud Computing and ...
(Date:2/28/2020)... ... February 26, 2020 , ... ... a high-speed camera with a dedicated controller, thus simplifying setup, streamlining integration, and ... HS7 is the first of Fastec Imaging’s new HS Series cameras to be ...
Breaking Biology Technology:
Cached News: